Susquehanna International Group, LLP Genetic Technologies LTD Call Options Transaction History

Susquehanna International Group, LLP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$0.0 - $0.0 $0 - $0	-1,300 Reduced 4.71%	26,300 $52,000
Q4 2021 Feb 14, 2022	BUY	$0.0 - $0.01 $0 - $14	1,400 Added 5.34%	27,600 $52,000
Q2 2021 Aug 11, 2021	BUY	$0.0 - $0.02 $0 - $306	15,300 Added 140.37%	26,200 $111,000
Q3 2020 Nov 16, 2020	BUY	$0.0 - $0.0 $0 - $0	10,900 New	10,900 $38,000

Ticker GENE
Exchange OTC
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 15,389,900
Market Cap $19.1M
Description
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.